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SUmmAry – The aim of our study was to describe and interpret national trends in thyroid 
cancer in Croatian men and women during the 1988-2010 period, to better understand the inciden-
ce and mortality trends in comparison with other populations, and to determine the proportion of 
certain histologic subtypes of thyroid cancer and their impact on these trends. Using information 
from the Croatian national Cancer registry and WhO mortality database, we estimated trends in 
the age-standardized incidence and mortality rates by joinpoint regression analysis. Thyroid cancer 
incidence increased in both women and men during the study period, with the estimated annual 
percent change (eAPC) of 6.4% and 5.5%, with no joinpoints identified. A significant decrease in 
mortality (eAPC -2.1%) was observed in women, while in men mortality rates decreased nonsigni-
ficantly (eAPC -1.3%). A statistically significant incidence increase was observed only for papillary 
carcinomas with annual incidence increase by 6.7% for women and 7.9% for men. during the study 
period, thyroid cancer showed an incidence increase in Croatia with persistent and steady decrease 
in mortality in women and statistically nonsignificant decrease in mortality in men. The increase in 
papillary carcinomas led to the thyroid cancer incidence increase and also affected the thyroid cancer 
mortality decrease in women. The trends observed are similar to those in other european countries 
and require additional analysis to determine all factors that have an effect on them.
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Introduction
Thyroid cancer is the most common malignant 
disease of the endocrine system1,2, making thyroid 
gland the ninth most common site of all cancers in 
women in the world and in europe3,4. According to 
the eUCAn estimates for 2012, there were around 
53 000 new cases and more than 6000 deaths from 
thyroid cancer in europe, with women accounting for 
77% of all new cases and 67% of deaths4. The trends 
observed are in favor of an increase in thyroid cancer 
incidence and a decrease in mortality5-8. in the US, 
thyroid cancer is the fastest increasing cancer in both 
sexes2. The risk factors for thyroid cancer are exposure 
to ionizing radiation, especially in childhood, having 
a history of goiter or thyroid nodules, family history 
of thyroid cancer, radioactive exposure, certain rare 
genetic syndromes, and female gender2,9-11. 
Changes in thyroid cancer incidence trends in 
particular countries have so far been associated with 
better medical diagnosis5 and were attributed to the 
increase of papillary carcinomas5,11, although not all 
changes could be explained so 12.  
The aim of this study was to describe and inter-
pret trends in the incidence and mortality of thyroid 
cancer in Croatian men and women during the 1988-
2010 period, to compare them with trends in other 
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populations and to identify possible changes, as well 
as to determine the proportion of certain histologic 
subtypes of thyroid cancer and their impact on the in-
cidence trends in the Croatian population.
Methods
Data sources
Thyroid cancer has been defined in the interna-
tional Classification of diseases as iCd-9 code 193 
and iCd-10 code C7313. incidence data for the study 
period were obtained from the Croatian national 
Cancer registry that includes the entire Croatian 
population (approximately 4.4 million persons)14. data 
are collected as mandatory cancer notifications from 
primary and secondary health care sources and death 
certificates from the Croatian Bureau of Statistics14. 
The registry has contributed data to the last three 
volumes of the Cancer incidence in Five Continents 
series15-17. The numbers of cancer deaths were obtained 
from the WhO mortality database18. For calculating 
age-specific rates we used the United nations popula-
tion estimates19.
data on histologic subtypes were available in the 
Croatian national Cancer registry for the period 
from 1998 to 2010. histologic subtype diagnosis was 
available in 94.5% of cases in this period and it was 
coded using the international Classification of dis-
eases for Oncology, third edition (iCd-O-3)20. To 
further analyze the impact of each histologic diagno-
sis on the incidence trends in our study, thyroid can-
cer was divided into three groups: papillary carcinoma 
(iCd-O-3 codes 8050, 8052, 8260, 8340), follicular 
carcinoma (iCd-O-3 codes 8290, 8330, 8331, 8332), 
and others. For these three histologic subgroups, age-
specific rates were calculated and used in further sta-
tistical analysis. data on tumor size could not be ob-
tained from the Croatian national Cancer registry.
Statistical analysis
Age-standardized rates (ASr) and truncated ASr 
(for ages 30-64) of cancer incidence in Croatia were 
calculated by the direct standardization method us-
ing the world standard population as a reference21. 
To describe the incidence and mortality trends by 
calendar period, we carried out joinpoint regression 
analysis using the Joinpoint regression Program, Ver-
sion 4.0.4., may 201322. The analysis included loga-
rithmic transformation of the rates, standard error, 
maximum number of five joinpoints, and minimum 
of four years between two joinpoints. All other pro-
gram parameters were set to default values. The aim of 
this approach is to identify possible joinpoints, where 
a significant change in the trend occurs. The method 
identifies joinpoints based on regression models with 
0-5 joinpoints. The final model selected was the most 
parsimonious of these, with the estimated annual per-
cent change (eAPC) based on the trend within each 
segment23. The same approach was used to calculate 
incidence trends of ASr for three histologic groups 
(papillary, follicular and others) in the 1998 to 2010 
period. Joinpoint regression analysis was also used to 
calculate incidence trends for age-specific rates of ten-
year age groups (30-39, 40-49, 50-59, 60-69, 70-79 
and >80 years).
On describing trends, the terms “significant in-
crease” or “significant decrease” denote that the slope 
of the trend was statistically significant (p<0.05). 
For statistically nonsignificant trends (p>0.05), we 
used the terms “stable” (for eAPC between -0.5% 
and 0.5%), “statistically nonsignificant increase” (for 
eAPC>0.5%), and “statistically nonsignificant de-
crease” (for eAPC <-0.5%). All statistical tests were 
two-sided.
Results
From 1988 to 2010, thyroid cancer was diagnosed 
in 5453 women and 1355 men (female-to-male ratio, 
4 to 1), while 542 women and 282 men died from this 
malignant disease (female-to-male ratio, 2 to 1). The 
median age at diagnosis could have been calculated 
only for the 1998-2010 period. We compared two 
three-year periods; in the first period (1998-2000), 
median age at diagnosis was 50 years, with inter-
quartile range of 40-62 years, and for the 2008-2010 
period, median age at diagnosis was 52 years, with 
interquartile range of 39-62 years.
Women
in women, the number of new cases ranged from 
99 to 409 annually in the study period, with the sig-
nificantly increasing trend, eAPC of 6.4% (95% con-
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Table 1. Thyroid cancer incidence and mortality in 
Croatian women 1988-2010
incidence mortality
year n Crude rate ASrW* n
Crude 
rate ASrW*
1988 133 5.7 4.5 28 1.2 0.7
1989 119 5.1 4.1 23 1.0 0.5
1990 144 6.2 4.7 29 1.2 0.7
1991 111 4.7 3.7 20 0.9 0.4
1992 99 4.2 3.1 25 1.1 0.6
1993 164 6.8 5.0 27 1.1 0.5
1994 123 5.1 3.8 26 1.1 0.6
1995 179 7.4 5.7 16 0.7 0.3
1996 166 6.9 5.4 24 1.0 0.5
1997 172 7.2 5.4 18 0.8 0.4
1998 184 7.7 5.8 30 1.7 0.6
1999 261 11.1 8.5 26 1.1 0.5
2000 253 10.8 8.3 19 0.8 0.5
2001 258 11.1 8.1 15 0.6 0.2
2002 268 11.6 8.6 25 1.1 0.4
2003 282 12.2 9.1 25 1.1 0.5
2004 293 12.7 9.4 22 0.9 0.4
2005 331 14.4 10.2 22 1.0 0.4
2006 325 14.1 10.3 27 1.2 0.5
2007 374 16.3 11.8 17 0.7 0.4
2008 403 17.6 12.8 32 1.4 0.6
2009 402 17.6 13.2 22 1.0 0.3
2010 409 17.9 13.2 24 1.1 0.4
*ASrW = age-standardized rate per 100 000 (using world standard 
population)
Table 2. Joinpoint analysis of age-specific and age-stan-
dardized rates of thyroid cancer incidence and mortality in 
Croatian women 1988-2010 
Age (years) Trendyears eAPC† (%95 Ci)
incidence
30-39 1988-2010 6.3* (4.7 to 8.0)
40-49 1988-2010 4.7* (3.0 to 6.5)
50-59 1988-2010 10.0* (8.1 to 11.9)
60-69 1988-2010 7.0* (5.4 to 8.7)
70-79 1988-2010 4.6* (2.8 to 6.4)
>80 1988-2010 -0.5 (-3.0 to 2.1)
Age-standardized
overall 1988-2010 6.4* (5.5 to 7.2)





60-69 1988-2010 -2.6 (-5.6 to 0.4)
70-79 1988-2010 -2.3 (-4.4 to 0.0)
>80 1988-2010 -0.5 (-3.0 to 2.1)
Age-standardized
overall 1988-2010 -2.1* (-3.6 to -0.6)
truncated (30-64) 1988-2010 n/A
n/A = not applicable due to insufficient number of cases; *statistically 
significant trend; †eAPC = estimated annual percent change
fidence interval [Ci], 5.5 to 7.2), with no joinpoints 
identified (Tables 1 and 2, Fig. 1). Significant increas-
ing trends in the incidence were observed in all 30-79 
age groups, with the most prominent increase (eAPC 
10%) in the 50-59 age-group (Table 2). A significant 
decrease in mortality (eAPC -2.1%, 95% Ci, -3.6 to 
-0.6) was observed in women in general; however, 
there was no significant change in age-specific mor-
tality trends (Table 2).
Men
in men, the number of new cases ranged from 23 to 
114 annually, with the significantly increasing eAPC 
Fig. 1. Joinpoint analysis of thyroid cancer incidence and 
mortality in Croatian women 1988-2010. 
Rhomb = incidence; triangle = mortality; ASR(W) = age-standardized rate 
per 100 000 (using world standard population)
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of 5.5% (95% Ci, 4.4 to 6.6), with no joinpoints identi-
fied (Tables 3 and 4, Fig. 2). The age-specific incidence 
trends were significantly increasing in the 30-69 age 
groups analyzed, with the most prominent increase of 
eAPC (8.1%) for incidence in the youngest 30-39 age 
group (Table 4). The age-standardized mortality rates 
decreased nonsignificantly with eAPC -1.3% (95% 
Ci, -3.5 to 1.0) (Table 4, Fig. 2). There were no sig-
nificant changes in mortality trends in men in any age 
group (Table 4).
Histologic groups
The number of new papillary carcinoma cases dou-
bled between the first and the last three-year period 
Table 3. Thyroid cancer incidence and mortality in 
Croatian men 1988-2010 
incidence mortality
year n Crude rate ASrW* n
Crude 
rate ASrW*
1988 42 1.9 1.9 21 1.0 0.7
1989 23 1.1 0.9 13 0.6 0.5
1990 35 1.6 1.2 8 0.4 0.3
1991 29 1.3 1.1 11 0.5 0.4
1992 27 1.2 1.0 8 0.4 0.2
1993 40 1.8 1.5 10 0.5 0.3
1994 32 1.4 1.2 9 0.4 0.5
1995 51 2.3 1.8 10 0.4 0.3
1996 41 1.8 1.4 18 0.8 0.5
1997 52 2.3 1.8 12 0.5 0.4
1998 43 1.9 1.4 8 0.4 0.2
1999 65 3.0 2.3 13 0.6 0.4
2000 70 3.2 2.3 19 0.9 0.5
2001 51 2.4 1.7 8 0.4 0.2
2002 59 2.7 2.0 12 0.6 0.3
2003 68 3.2 2.3 11 0.5 0.3
2004 82 3.8 2.7 16 0.7 0.4
2005 82 3.8 2.7 13 0.6 0.3
2006 86 4.0 3.0 9 0.4 0.2
2007 73 3.4 2.4 12 0.6 0.3
2008 94 4.4 3.2 15 0.7 0.4
2009 114 5.4 3.8 7 0.3 0.2
2010 96 4.5 3.2 19 0.9 0.6
*ASrW = age-standardized rate per 100 000 (using world standard 
population) ledra in 
Table 4. Joinpoint analysis of age-specific and age-stan-
dardized rates of thyroid cancer incidence and mortality in 
Croatian men 1988-2010 
Age (years) Trendyears eAPC† (%95 Ci)
incidence
30-39 1988-2010 8.1* (5.2 to 11.0)
40-49 1988-2010 5.3* (3.0 to 7.6)
50-59 1988-2010 7.3* (5.2 to 9.5)




overall 1988-2010 5.5* (4.4 to 6.6)









overall 1988-2010 -1.3 (-3.5 to 1.0)
truncated (30-64) 1988-2010 -1.0 (-4.0 to 2.0)
n/A = not applicable due to insufficient number of cases; *statistically 
significant trend; †eAPC = estimated annual percent change
Rhomb = incidence; triangle = mortality; ASR(W) = age-standardized rate 
per 100 000 (using world standard population)
Fig. 2. Joinpoint analysis of thyroid cancer incidence and 
mortality in Croatian men 1988-2010. 
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(1998-2000 and 2008-2010). The number of follicular 
and medullary carcinoma cases increased 1.1- and 1.6-
fold, while the number of anaplastic carcinoma was 
unchanged. The proportion of papillary carcinoma in 
overall thyroid cancer rose from 81% to 87%, while 
the proportion of other subgroups decreased from 
12.8% to 8.1% for follicular carcinoma, from 4.5% to 
4.1% for medullary carcinoma, and from 1.7% to 0.9% 
for anaplastic carcinoma. 
Joinpoint analysis of three broad histologic groups 
of thyroid cancer (papillary, follicular and other speci-
fied or not otherwise specified carcinomas) indicated a 
statistically significant incidence increase in the study 
period only for papillary carcinomas (Table 5). The an-
nual incidence increase was 6.7% in women (95% Ci, 
5.8 to 7.7) and 7.9% in men (95% Ci, 5.0 to 10.9).
Discussion
Time trends of thyroid cancer incidence and mor-
tality were for the first time systematically analyzed in 
Croatia by joinpoint regression modeling that is the 
optimal method to detect and depict sharp changes 
in trends, reflecting changes in cancer prevention and 
care policies.
Our results indicated an increase in thyroid cancer 
incidence in Croatia in both sexes between 1988 and 
2010, with persistent and steady decrease in mortality 
in women and statistically nonsignificant decrease in 
mortality in men. The most prominent incidence in-
crease was observed in the 50-59 age group in women 
and in the youngest 30-39 age group in men. 
From the 1970s, incidence rates increased in most 
european countries, although a decrease was recorded 
in some countries, such as Sweden and norway24. ris-
ing incidence trends are also observed in non-euro-
pean countries, such as US and Canada5,25. in the last 
fifty years (1960-2004), mortality from thyroid cancer 
declined in europe in both sexes and the falls tended 
to be larger in women26.
According to the observed thyroid cancer incidence 
of ASr 11.4/100 000, Croatia is ranked as the fourth 
european country with the highest thyroid cancer in-
cidence. higher incidence rates than in Croatia are 
registered only in lithuania (15.5/100 000), italy 
(13.5/100 000) and Austria (12.4/100 000)4. With 
the observed thyroid cancer mortality of ASr 0.5/100 
000, Croatia is ranked the 17th of 40 european coun-
tries4. The highest mortality ASr in europe was ob-
served in russia (1.1/100 000), iceland (0.8/100 000) 
and lithuania (0.7/100 000)4. 
When analyzing trends by sex, we can claim that 
Croatia, compared to other european countries from 
the eUCAn database, has a high female and male 
thyroid incidence and moderate mortality4. Countries 
with the highest incidence rates among women are 
lithuania (24.2/100 000) and italy (18.7/100 000) 
and with the highest mortality rates russia (1.3/100 
000) and latvia (0.9/100 000)4. Similar country or-
der applies to men; by incidence, Croatia ranks fifth 
after italy, Austria, luxembourg and France, while 
by mortality of thyroid cancer in men, Croatia ranks 
ninth after iceland, russia, Cyprus, lithuania, Slove-
nia, hungary, italy and Austria4.
despite various explanations in the past, recent 
studies suggest that the reasons for increase in the in-
cidence are not completely understood12 and that the 
cause is most likely multifactorial27. liu et al. suggest 
etiologic heterogeneity between women and men in the 
pathogenesis of thyroid cancer5. The majority of authors 
are in favor of more intensive diagnostics as the rea-
son for the increasing trends. Advanced medical pro-
cedures such as ultrasound and fine-needle aspiration 
biopsy have contributed to detection of thyroid cancer, 
especially smaller ones. Against these claims are results 
such as the increase of thyroid cancers larger than 4 
cm24,28. Also, our results suggest that despite the in-
cidence increase, there is no increase in thyroid cancer 
mortality. These findings could be explained in two 
ways. One is that cancer treatment in Croatia is at a 
high level. The second possible answer is that carcino-
mas, mostly microcarcinomas that make the majority 
of newly diagnosed thyroid cancers, are clinically non-
significant29. The size of tumors could not be obtained 
Table 5. Incidence trends of thyroid cancer according to 
subgroups and sex 1998-2010
1998-2010 Women men
eAPC† (95% Ci) eAPC† (95% Ci)
Papillary 6.7* (5.8 to 7.7) 7.9* (5.0 to 10.9)
Follicular 2.1 (-2.0 to 6.3) -0.7 (-8.4 to 7.6)
Others -0.7 (-5.7 to 4.5) 0.3 (-6.0 to 7.0)
*Statistically significant trend; †eAPC = estimated annual percent 
change
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from the Croatian national Cancer registry and there-
fore trends in tumor size were not part of our analysis. 
iodine intake was also analyzed as a possible explana-
tion for changes in thyroid cancer trends, and increase 
in the incidence of thyroid cancer in Croatia cannot be 
attributed to the increased iodine intake30,31.
According to the data obtained, it can be conclud-
ed that the incidence increase is almost entirely due 
to the increase in papillary carcinoma. Similar trends 
are observed by other authors5,11,12,32. in the study by 
howlader et al., as well as in our study, six of seven 
thyroid cancers were papillary carcinomas33. The in-
crease of papillary carcinomas, which have better 
clinical outcome in comparison with other histologic 
subtypes of thyroid cancer, also has influenced the 
mortality decrease in women in Croatia. 
An interesting fact was found when Croatia was 
compared with other countries in southeast europe. 
Croatia as a country with high incidence rates is an 
exception, since other countries in this part of europe 
have the lowest incidence rates in all europe, eAPC 
<3.6/100 0004. more than 20 years ago, the majority 
of these countries were parts of former yugoslavia and 
were involved in the war in the 1990s. These countries 
have the same geographical position, in yugoslavia had 
shared similar health care system, and had similar expo-
sure to external factors. Griniatsos et al. have discussed 
the Chernobyl accident from 1986 and depleted ura-
nium weapons during the 1990s war on the former yu-
goslavia territory as the possible factors influencing thy-
roid cancer trends in Greece, however, with no proven 
correlation10. All the above mentioned imposes further 
thoughts. if the reason for incidence increase is inten-
sive diagnostics, does it mean that Croatia has the most 
optimal diagnostics, even better than some developed 
eU countries? if the reasons for high incidence are ex-
ternal factors such as Chernobyl and war, why are there 
such differences between geographically neighboring 
countries that had the same or similar exposure? An-
other possible explanation for the observed difference 
between Croatia and other countries in southeast eu-
rope could possibly be found in cancer registries of these 
countries, the way they are organized and differences in 
data collection. These differences are striking and de-
mand thorough investigation and further analysis. 
Among european countries, there is certain regu-
larity in mortality distribution; the highest rates are 
recorded in the east of europe and these rates de-
crease toward countries in the west of europe, with 
few exceptions4. Whether this is so because of better 
thyroid cancer treatment or earlier diagnosis in west-
ern european countries, or there are other factors, is 
yet to be analyzed. 
in Croatia, thyroid cancer showed an incidence in-
crease in both sexes during the 23-year study period, 
with a significant decrease in mortality in women and 
nonsignificant decrease in mortality in men. The in-
cidence increase of thyroid cancer can be attributed 
to the increase of papillary carcinomas. The trends 
observed are similar to those in other european coun-
tries and require additional analysis to determine the 
factors influencing these trends. 
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Sažetak
TrendOVi U inCidenCiJi i SmrTnOSTi KArCinOmA ŠTiTnJAČe U hrVATSKOJ U rAZdOBlJU 
Od 1988. dO 2010. GOdine
L. Vučemilo, T. Znaor, T. Kuliš, M. Šekerija i A. Znaor
Cilj ovoga rada bio je opisati i protumačiti trendove incidencije i smrtnosti karcinoma štitnjače u hrvatskoj u razdoblju 
od 1988. do 2010. godine, usporediti ih s trendovima u drugim zemljama te odrediti udio histoloških tipova karcinoma 
štitnjače i njihov utjecaj na trendove. Koristeći podatke iz registra za rak hrvatske i iz baze podataka Svjetske zdrav-
stvene organizacije učinjena je regresijska analiza uz pomoć točaka spajanja za procjenu trendova incidencije i smrtnosti. 
incidencija karcinoma štitnjače porasla je i kod žena i kod muškaraca u promatranom razdoblju s procijenjenim godišnjim 
postotkom promjene (engl. estimated annual percent change, eAPC) od 6,4% i 5,5%, bez identificiranih točaka spajanja. 
Kod žena je zabilježen značajan pad smrtnosti (eAPC -2,1%), dok se kod muškaraca smrtnost smanjila, ali statistički 
neznačajno (eAPC -1,3%). Statistički značajan porast incidencije zabilježen je samo kod papilarnih karcinoma s godiš-
njim postotkom promjene od 6,7% za žene i 7,9% za muškarce. incidencija karcinoma štitnjače porasla je u promatranom 
razdoblju uz stalan i umjeren pad smrtnosti kod žena te uz statistički neznačajan pad smrtnosti kod muškaraca. incidencija 
karcinoma štitnjače je porasla zbog porasta broja papilarnih karcinoma, što je također utjecalo na pad smrtnosti od karci-
noma štitnjače kod žena. Zabilježeni trendovi su slični trendovima u drugim europskim zemljama i zahtijevaju dodatnu 
analizu svih čimbenika koji na njih utječu. 
Ključne riječi: Štitnjača, tumori – epidemiologija; Štitnjača, tumori – trendovi; Hrvatska 
